Long acting beta adrenoceptor agonist

(Redirected from Beta-agonists)
Jump to navigation Jump to search

WikiDoc Resources for Long acting beta adrenoceptor agonist

Articles

Most recent articles on Long acting beta adrenoceptor agonist

Most cited articles on Long acting beta adrenoceptor agonist

Review articles on Long acting beta adrenoceptor agonist

Articles on Long acting beta adrenoceptor agonist in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Long acting beta adrenoceptor agonist

Images of Long acting beta adrenoceptor agonist

Photos of Long acting beta adrenoceptor agonist

Podcasts & MP3s on Long acting beta adrenoceptor agonist

Videos on Long acting beta adrenoceptor agonist

Evidence Based Medicine

Cochrane Collaboration on Long acting beta adrenoceptor agonist

Bandolier on Long acting beta adrenoceptor agonist

TRIP on Long acting beta adrenoceptor agonist

Clinical Trials

Ongoing Trials on Long acting beta adrenoceptor agonist at Clinical Trials.gov

Trial results on Long acting beta adrenoceptor agonist

Clinical Trials on Long acting beta adrenoceptor agonist at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Long acting beta adrenoceptor agonist

NICE Guidance on Long acting beta adrenoceptor agonist

NHS PRODIGY Guidance

FDA on Long acting beta adrenoceptor agonist

CDC on Long acting beta adrenoceptor agonist

Books

Books on Long acting beta adrenoceptor agonist

News

Long acting beta adrenoceptor agonist in the news

Be alerted to news on Long acting beta adrenoceptor agonist

News trends on Long acting beta adrenoceptor agonist

Commentary

Blogs on Long acting beta adrenoceptor agonist

Definitions

Definitions of Long acting beta adrenoceptor agonist

Patient Resources / Community

Patient resources on Long acting beta adrenoceptor agonist

Discussion groups on Long acting beta adrenoceptor agonist

Patient Handouts on Long acting beta adrenoceptor agonist

Directions to Hospitals Treating Long acting beta adrenoceptor agonist

Risk calculators and risk factors for Long acting beta adrenoceptor agonist

Healthcare Provider Resources

Symptoms of Long acting beta adrenoceptor agonist

Causes & Risk Factors for Long acting beta adrenoceptor agonist

Diagnostic studies for Long acting beta adrenoceptor agonist

Treatment of Long acting beta adrenoceptor agonist

Continuing Medical Education (CME)

CME Programs on Long acting beta adrenoceptor agonist

International

Long acting beta adrenoceptor agonist en Espanol

Long acting beta adrenoceptor agonist en Francais

Business

Long acting beta adrenoceptor agonist in the Marketplace

Patents on Long acting beta adrenoceptor agonist

Experimental / Informatics

List of terms related to Long acting beta adrenoceptor agonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

They are designed to replace the shorter acting B2-agonists such as salbutamol, as they have a duration of action of approximately 12 hours in comparison with the 4-6 hour duration of salbutamol, making them ideal candidates for twice-daily administration.

Indication

Long acting beta-adrenoceptor agonists are usually prescribed for moderate to severe persistent asthma patients or patients with COPD.

Types

Some long acting beta-adrenoceptor agonists are:

Template:Asthma and copd rx


Template:WikiDoc Sources